Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.43 |
| ▸ | CA2 | P00918 | 8/20 | 0.43 |
| ▸ | CA9 | Q16790 | 6/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 4/20 | 0.41 |
| ▸ | CA7 | P43166 | 4/20 | 0.41 |
| ▸ | CA6 | P23280 | 3/20 | 0.41 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 3/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1470495 | 0.86 | KMT2A (0.41) | CA1CA2CA9CA4CA7 | |
| SCHEMBL1471222 | 0.86 | KMT2A (0.41) | CA1CA2CA9CA4CA7 | |
| SCHEMBL4740697 | 0.86 | KMT2A (0.41) | CA1CA2CA9CA4CA7 | |
| SCHEMBL14538800 | 0.83 | KMT2A (0.39) | CA1CA2CA9CA4CA7 | |
| SCHEMBL9979464 | 0.81 | CA1 (0.46) | CA1CA2CA9CA7CA12 | |
| SCHEMBL2071684 | 0.80 | KMT2A (0.44) | KMT2AF2F10ALDH1A1MTNR1A | |
| SCHEMBL30967925 | 0.80 | KMT2A (0.44) | CA1CA2KMT2AF2F10 | |
| SCHEMBL1081324 | 0.80 | KMT2A (0.44) | KMT2AF2F10ALDH1A1MTNR1A | |
| SCHEMBL4013407 | 0.80 | KMT2A (0.44) | CA1CA2KMT2AF2F10 | |
| Hydrochloric Acid SCHEMBL2071681 | 0.78 | KMT2A (0.43) | KMT2AF2F10MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080287477-A1 | Novel Compounds as Modulators of Ppar | KALYPSYS, INC. (US) | 2008-11-20 | — | — | US | disclosed |
| WO-2007047432-A1 | SULFONAMIDE DERIVATIVES AS MODULATORS OF PPAR | KALYPSYS, INC. (US) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287477-A1 | Novel Compounds as Modulators of Ppar | PPARG, PPARA, PPARD | CA1 4799/4885CA2 4470/4885CA9 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.